Literature DB >> 4849166

[Metabolism and pharmacokinetics of calcium dobesilate in humans].

A Benakis, B Glasson, C A Bouvier, J Ritschard, B Krahenbuhl, A Jung, H J Hachen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4849166

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration.

Authors:  C T Plessas; P Karayannakos; S T Plessas; A Costakis; I Donta; G Skalkeas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

2.  Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Sebastián Videla; Iñigo Sáenz de Tejada
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

3.  Strong Negative Interference by Calcium Dobesilate in Sarcosine Oxidase Assays for Serum Creatinine Involving the Trinder Reaction.

Authors:  Xiuzhi Guo; Li'an Hou; Xinqi Cheng; Tianjiao Zhang; Songlin Yu; Huiling Fang; Liangyu Xia; Zhihong Qi; Xuzhen Qin; Lin Zhang; Qian Liu; Li Liu; Shuling Chi; Yingying Hao; Ling Qiu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Negative interferences by calcium dobesilate in the detection of five serum analytes involving Trinder reaction-based assays.

Authors:  Xiuzhi Guo; Li'an Hou; Yicong Yin; Jie Wu; Fang Zhao; Liangyu Xia; Xinqi Cheng; Qian Liu; Li Liu; Ermu Xu; Ling Qiu
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

Review 5.  Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

Authors:  Hervé Allain; Albert A Ramelet; Elisabeth Polard; Danièle Bentué-Ferrer
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.